switching from compounded semaglutide to wegovy vs. Ozempic: What Know How to Safely Switch from
Description
Cyberpsychology, Behavior, and Social Networking , 16(3), 224-231.
Biweekly dosing has not been studied for its safety and efficacy in clinical trials
[DOI] [PubMed] [Google Scholar] 57.Marso S.P., Bain S.C., Consoli A., Eliaschewitz F.G., Jdar E., Leiter L.A., Lingvay I., Rosenstock J., Seufert J., Warren M.L., et al
Dual GIP/GLP-1 receptor co-agonists The discovery of the first GIP/GLP-1 receptor co-agonist was reported in 2013 [74]
Current guidelines lack clarity in regard to these differences and more reliable risk estimates require further investigation (Ushakumari and Sladen 2024)
